Metformin and its Effects on Myocardial Dimension and Left ventricular hypertrophy in Normotensive patients with Coronary Heart Disease (The MET-REMODEL Study): Rationale and Design of the MET-REMODEL Study

Effect of Metformin on Left Ventricular Function After Acute Myocardial Infarction in Patients Without Diabetes

(2014) Chris P. H. Lexis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease

(2013) Sushma Rekhraj et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial

(2013) David Preiss et al.   Lancet Diabetes & Endocrinology

Metformin-based treatment for obesity-related hypertension

(2012) Hongbo He et al.   JOURNAL OF HYPERTENSION

Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation

(2011) Yong-nan Fu et al.   ACTA PHARMACOLOGICA SINICA

Mechanistic Insights Into the Therapeutic Use of High-Dose Allopurinol in Angina Pectoris

(2011) Narasimharajapura S. Rajendra et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Metformin Inhibits Isoproterenol-induced Cardiac Hypertrophy in Mice

(2011) Hye-Na Cha et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Mechanisms linking obesity to hypertension

(2011) J. A. N. Dorresteijn et al.   Obesity Reviews

Metformin Use and Mortality Among Patients With Diabetes and AtherothrombosisMetformin Use With Diabetes and Atherothrombosis

(2010) Ronan Roussel   ARCHIVES OF INTERNAL MEDICINE

Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats

(2010) Cheng-Xi Zhang et al.   CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY

Biomarkers and Surrogate Endpoints in Cardiovascular Therapeutics Research: Under Scrutiny Following Results of the ENHANCE Study

(2008) Maheshwar Pauriah et al.   Cardiovascular Therapeutics

Insulin Resistance: A Potential New Target for Therapy in Patients with Heart Failure

(2008) Aaron K.F. Wong et al.   Cardiovascular Therapeutics

Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure

(2008) Susheel Gundewar et al.   CIRCULATION RESEARCH

AMP Activated Protein Kinase-α2 Deficiency Exacerbates Pressure-Overload–Induced Left Ventricular Hypertrophy and Dysfunction in Mice

(2008) Ping Zhang et al.   HYPERTENSION

Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation

(2008) Ashwin Akki et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY